Highmark Suit Says UPMC Overbilled $300M For Chemo Drugs
Highmark Inc. accused the University of Pittsburgh Medical Center on Wednesday of systemically overbilling the insurer and its members for chemotherapy drugs and services by more than $300 million over the...To view the full article, register now.
Already a subscriber? Click here to view full article